In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

ESC TV - Guidelines

News and opinion on the latest ESC Clinical Practice Guidelines

Watch now

Peripheral Arterial Diseases (Diagnosis and Treatment of)

ESC Clinical Practice Guidelines

Prevention
Peripheral Vascular Intervention
Peripheral Arterial Diseases
Guidelines version available to download
Published in 2017
Reference PAD
Published in 2017
Reference PAD
Q&A
Published in 2017
Reference PAD
Published in 2017
Reference PAD
Published in 2017
Reference PAD Slides
App
Published in 2017
Reference Pocket Guideliines App
Published in 2011
Reference European Heart Journal (2011) 32, 2851–2906; doi:10.1093/eurheartj/ehr211
Table of contents: Full Text (ESC Clinical Practice Guidelines)

1. Preamble
2. Introduction.
3. Epidemiology and risk factors
  3.1 Epidemiology
  3.2 Risk factors
  3.3 Prognosis
4.General aspects
  4.1.Diagnostic approach
  4.2 Treatment approach
5.Antithrombotic drugs in PADs
  5.1 Antithrombotic treatment in carotid artery disease
  5.2 Antithrombotic therapy in lower extremity artery disease.
  5.3 Antithrombotic therapy in lower extremity artery disease patients requiring long-term oral anticoagulant
  5.4 Antithrombotic therapy after endovascular therapy in other territories
6. Extracranial carotid and vertebral artery disease
  6.1 Carotid artery disease
  6.2 Vertebral artery disease
7.Upper extremity artery disease.
  7.4Diagnosticmethods
  7.5 Treatment
8.Mesenteric artery disease
  8.1 Acute mesenteric ischaemia
  8.2 Chronicmesenteric artery disease
9.Renal artery disease
  9.1 Introduction
  9.2 Clinical presentation
  9.3 Natural history
  9.4 Diagnostic strategy
  9.5 Prognosis
  9.6 Treatment
10. Lower extremity artery disease
  10.1. Clinical presentation and natural history
  10.2 Diagnostic tests
  10.3 Medical treatment
  10.4 Revascularization options: general aspects
  10.5 Management of intermittent claudication
  10.6 Chronic limb-threatening ischaemia
  10.7Acute limb ischaemia
  10.8 Blue toe syndrome
11. Multisite artery disease
  11.1 Multisite artery disease: epidemiology and impact prognosis.
  11.2 Screening for and management of multisite artery disease
12. Cardiac conditions in peripheral arterial diseases
  12.1 Introduction
  12.2 Heart failure and peripheral arterial diseases
  12.3 Peripheral arterial diseases and atrial fibrillation
  12.4 Peripheral arterial diseases and valvular heart disease
  12.5 Peripheral arterial diseases and vascular access site for cardiac interventions
13. Gaps in evidence
14. To do and not to do messages from the Guidelines
15.Web addenda and companion document
16. Appendix
17. References